Gastroesophageal Reflux disease - Pipeline Insight, 2021

Publisher Name :
Date: 15-Mar-2021
No. of pages: 60
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's, "Gastroesophageal Reflux disease - Pipeline Insight, 2021," report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Gastroesophageal Reflux disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Geography Covered

- Global coverage

Gastroesophageal Reflux disease Understanding

Gastroesophageal Reflux disease: Overview

Gastro-oesophageal reflux disease (GORD) is a common condition, where acid from the stomach leaks up into the oesophagus (gullet). It usually occurs as a result of the ring of muscle at the bottom of the oesophagus becoming weakened. Read more about the causes of GORD. GORD causes symptoms such as heartburn and an unpleasant taste in the back of the mouth. It may just be an occasional nuisance for some people, but for others it can be a severe, lifelong problem. GORD can often be controlled with self-help measures and medication. Occasionally, surgery to correct the problem may be needed.

"Gastroesophageal Reflux disease - Pipeline Insight, 2021" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Gastroesophageal Reflux disease pipeline landscape is provided which includes the disease overview and Gastroesophageal Reflux disease treatment guidelines. The assessment part of the report embraces, in depth Gastroesophageal Reflux disease commercial assessment and clinical assessment of the pipeline products under development. In the report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Gastroesophageal Reflux disease collaborations, licensing, mergers and acquisition, funding, designations and other product related details.

Report Highlights

- The companies and academics are working to assess challenges and seek opportunities that could influence Gastroesophageal Reflux disease R&D. The therapies under development are focused on novel approaches to treat/improve Gastroesophageal Reflux disease.

Gastroesophageal Reflux disease Emerging Drugs Chapters

This segment of the Gastroesophageal Reflux disease report encloses its detailed analysis of various drugs in different stages of clinical development, including phase II, I, preclinical and Discovery. It also helps to understand clinical trial details, expressive pharmacological action, agreements and collaborations, and the latest news and press releases.

Gastroesophageal Reflux disease Emerging Drugs

- Fexuprazan: Daewoong Pharmaceutical

Fexuprazan is a novel potassium-competitive acid blocker (P-CAB) developed by Daewoong, which reversibly blocks the proton pump that secretes gastric acids located in the cannalicular membrane. It is a next-generation of proton pump inhibitors (PPI), which are widely used for gastroesophageal reflux disease (GERD). The drug is in preregistration stage for the treatment of gastroesophageal reflux disease.

- JP 1366: Jeil Pharmaceutical

JP 1366 belongs to the class of Antiulcers. The drug is being developed by Jeil Pharmaceuticals for the treatment of gastroesophageal reflux disease and is currently in phase II of clinical trials.

Further product details are provided in the report……..

Gastroesophageal Reflux disease: Therapeutic Assessment

This segment of the report provides insights about the different Gastroesophageal Reflux disease drugs segregated based on following parameters that define the scope of the report, such as:

- Major Players in Gastroesophageal Reflux disease

There are approx. 3+ key companies which are developing the therapies for Gastroesophageal Reflux disease. The companies which have their Gastroesophageal Reflux disease drug candidates in the most advanced stage, i.e. preregistration include, Daewoong Pharmaceutical

- Phases

DelveInsight's report covers around 3+ products under different phases of clinical development like

- Late stage products (Phase III)

- Mid-stage products (Phase II)

- Early-stage product (Phase I) along with the details of

- Pre-clinical and Discovery stage candidates

- Discontinued & Inactive candidates

- Route of Administration

Gastroesophageal Reflux disease pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

- Oral

- Subcutaneous

- Intravenous

- Intramuscular

- Molecule Type

Products have been categorized under various Molecule types such as

- Bispecific Antibody

- Peptides

- Small molecule

- Gene therapy

- Product Type

Drugs have been categorized under various product types like Mono, Combination and Mono/Combination.

Gastroesophageal Reflux disease: Pipeline Development Activities

The report provides insights into different therapeutic candidates in phase II, I, preclinical and discovery stage. It also analyses Gastroesophageal Reflux disease therapeutic drugs key players involved in developing key drugs.

Pipeline Development Activities

The report covers the detailed information of collaborations, acquisition and merger, licensing along with a thorough therapeutic assessment of emerging Gastroesophageal Reflux disease drugs.

Gastroesophageal Reflux disease Report Insights

- Gastroesophageal Reflux disease Pipeline Analysis

- Therapeutic Assessment

- Unmet Needs

- Impact of Drugs

Gastroesophageal Reflux disease Report Assessment

- Pipeline Product Profiles

- Therapeutic Assessment

- Pipeline Assessment

- Inactive drugs assessment

- Unmet Needs

Key Questions

Current Treatment Scenario and Emerging Therapies:

- How many companies are developing Gastroesophageal Reflux disease drugs?

- How many Gastroesophageal Reflux disease drugs are developed by each company?

- How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Gastroesophageal Reflux disease?

- What are the key collaborations (Industry-Industry, Industry-Academia), Mergers and acquisitions, licensing activities related to the Gastroesophageal Reflux disease therapeutics?

- What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?

- What are the clinical studies going on for Gastroesophageal Reflux disease and their status?

- What are the key designations that have been granted to the emerging drugs?

Key Players

- Daewoong Pharmaceutical

- Jeil Pharmaceutical

- Effexus Pharmaceutical

- Addpharma

Key Products

- Fexuprazan

- JP 1366

- Lansoprazole/omeprazole

- AD 214

Gastroesophageal Reflux disease - Pipeline Insight, 2021

Table of Contents

Introduction
Executive Summary
Gastroesophageal Reflux disease: Overview
* Causes
* Mechanism of Action
* Signs and Symptoms
* Diagnosis
* Disease Management
Pipeline Therapeutics
* Comparative Analysis
Therapeutic Assessment
* Assessment by Product Type
* Assessment by Stage and Product Type
* Assessment by Route of Administration
* Assessment by Stage and Route of Administration
* Assessment by Molecule Type
* Assessment by Stage and Molecule Type
Gastroesophageal Reflux disease - DelveInsight's Analytical Perspective
In-depth Commercial Assessment
* Gastroesophageal Reflux disease companies' collaborations, Licensing, Acquisition -Deal Value Trends
Gastroesophageal Reflux disease Collaboration Deals
* Company-Company Collaborations (Licensing / Partnering) Analysis
* Company-University Collaborations (Licensing / Partnering) Analysis
Late Stage Products (Phase III)
* Comparative Analysis
Fexuprazan : Daewoong Pharmaceutical
* Product Description
* Research and Development
* Product Development Activities
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
* Comparative Analysis
JP 1366: Jeil Pharmaceutical
* Product Description
* Research and Development
* Product Development Activities
Drug profiles in the detailed report…..
Early Stage Products (Phase I)
* Comparative Analysis
AD 214: Addpharma
* Product Description
* Research and Development
* Product Development Activities
Drug profiles in the detailed report…..
Inactive Products
* Comparative Analysis
Gastroesophageal Reflux disease Key Companies
Gastroesophageal Reflux disease Key Products
Gastroesophageal Reflux disease- Unmet Needs
Gastroesophageal Reflux disease- Market Drivers and Barriers
Gastroesophageal Reflux disease- Future Perspectives and Conclusion
Gastroesophageal Reflux disease Analyst Views
Gastroesophageal Reflux disease Key Companies
Appendix

List of Tables

Table 1 Total Products for Gastroesophageal Reflux disease
Table 2 Late Stage Products
Table 3 Mid Stage Products
Table 4 Early Stage Products
Table 5 Pre-clinical & Discovery Stage Products
Table 6 Assessment by Product Type
Table 7 Assessment by Stage and Product Type
Table 8 Assessment by Route of Administration
Table 9 Assessment by Stage and Route of Administration
Table 10 Assessment by Molecule Type
Table 11 Assessment by Stage and Molecule Type
Table 12 Inactive Products

List of Figures

Figure 1 Total Products for Gastroesophageal Reflux disease
Figure 2 Late Stage Products
Figure 3 Mid Stage Products
Figure 4 Early Stage Products
Figure 5 Preclinical and Discovery Stage Products
Figure 6 Assessment by Product Type
Figure 7 Assessment by Stage and Product Type
Figure 8 Assessment by Route of Administration
Figure 9 Assessment by Stage and Route of Administration
Figure 10 Assessment by Molecule Type
Figure 11 Assessment by Stage and Molecule Type
Figure 12 Inactive Products
  • China Lansoprazole Market Report & Forecast 2021-2027
    Published: 15-Nov-2021        Price: US 3400 Onwards        Pages: 105
    China Lansoprazole Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units) China Lansoprazole Market Segment Percentages, By Type, 2020 (%) - Capsules - Tablets - Injection China Lansoprazole Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units) China Lansoprazole Market Segment Percentages, By Application, 2020 (%) - Male - Female Competitor Analysis The report also provides analysis of ......
  • China Inflammatory Bowel Disease Drugs Market Report & Forecast 2021-2027
    Published: 12-Nov-2021        Price: US 3400 Onwards        Pages: 94
    China Inflammatory Bowel Disease Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units) China Inflammatory Bowel Disease Drugs Market Segment Percentages, By Type, 2020 (%) - Amino-salicylates - Antibiotics - Corticosteroids - Immunomodulators - Biologics - Others China Inflammatory Bowel Disease Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units) China Inflammatory Bowel Disease Drugs Ma......
  • China Esomeprazole Market Report & Forecast 2021-2027
    Published: 10-Nov-2021        Price: US 3400 Onwards        Pages: 93
    China Esomeprazole Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units) China Esomeprazole Market Segment Percentages, By Type, 2020 (%) - Capsule - Tablet - Others China Esomeprazole Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units) China Esomeprazole Market Segment Percentages, By Application, 2020 (%) - Gastroesophageal Reflux Disease - Duodenal Ulcers - Others Competitor Analys......
  • China Anti Peptic Ulcer Drugs Market Report & Forecast 2021-2027
    Published: 03-Nov-2021        Price: US 3400 Onwards        Pages: 90
    China Anti Peptic Ulcer Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units) China Anti Peptic Ulcer Drugs Market Segment Percentages, By Type, 2020 (%) - Proton Pump Inhibitors (PPIs) - Potassium-Competitive Acid Blockers (P-CAB) - Antacids - H2 Antagonists - Antibiotics - Ulcer Protective Drugs China Anti Peptic Ulcer Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units) China Anti Pept......
  • Global Irritable Bowel Syndrome (IBS) Market 2021 by Company, Regions, Type and Application, Forecast to 2026
    Published: 01-Nov-2021        Price: US 3480 Onwards        Pages: 81
    The Irritable Bowel Syndrome (IBS) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our......
  • China Drugs for Traveler's Diarrhea Market Report & Forecast 2021-2027
    Published: 22-Oct-2021        Price: US 3400 Onwards        Pages: 90
    China Drugs for Traveler's Diarrhea Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Drugs for Traveler's Diarrhea Market Segment Percentages, By Type, 2020 (%) - Anti-motility agents - Bismuth Subsalicylate (Pepto-Bismol) - Antibiotics China Drugs for Traveler's Diarrhea Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Drugs for Traveler's Diarrhea Market Segment Percentages, By Application, 2020 (%)......
  • Global Gastroparesis Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 21-Oct-2021        Price: US 3480 Onwards        Pages: 90
    The Gastroparesis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest res......
  • Peptic Ulcer - Pipeline Insight, 2021
    Published: 12-Oct-2021        Price: US 1500 Onwards        Pages: 60
    DelveInsight's, "Peptic Ulcer - Pipeline Insight, 2021," report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Peptic Ulcer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered - Global coverage......
  • Global Anti-Peptic Ulcer Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026
    Published: 08-Oct-2021        Price: US 3480 Onwards        Pages: 93
    The Anti-Peptic Ulcer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs